Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

AIDS

Volumn 14, Issue 13, 2000, Pages 1921-1933

  Plana, Montserrat ^a   García, Felipe ^a   Gallart, Teresa ^a   Tortajada, Cecilia ^a   Soriano, Alex ^a   Palou, Eduard ^a   Maleno, María J ^a   Barceló, Juan J ^a   Vidal, Carmen ^a   Cruceta, Anna ^a   Miró, José M ^a   Gatell, José M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Cellular factors cytokines; Cellular immunity; Early antiretroviral therapy; HIV 1; Immune restoration; T cell subsets

Indexed keywords

ANTIRETROVIRUS AGENT; CD28 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LAMIVUDINE; RITONAVIR; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADP-RIBOSYL CYCLASE; ANTI-HIV AGENTS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, CCR5; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

EID: 0034623019     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200009080-00007     Document Type: Article

References (56)

1. New concepts in the immunopathogenesis of HIV infection
2. Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons
3. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
4. Failure of T cell homeostasis preceding AIDS in HIV-1 infection. The multicenter AIDS cohort study
5. CD8 naive T cell counts decrease progressively in HIV-infected adults
6. CD8 CD38 and CD8 DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4 cell counts and proliferation to mitogens
7. Increased numbers of primed activated CD8 CD38 CD45RO+ T cells predict the decline of CD4 T cells in HIV-1-infected patients
8. Elevated levels of CD38 CD8 T cells in HIV infection add to the prognostic value of low CD4 T cell levels: Results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study
9. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1
10. Contribution of CD4, CD8 CD28+, and CD8 CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection
11. - T cells in vertically HIV-infected children
12. Preferential infection of CD4 memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T cell functional defects observed in infected individuals
13. HIV infection induces changes in CD4 T cell phenotype and depletions within the CD4 T cell repertoire that are not immediately restored by antiviral or immune-based therapies
14. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexuel men
15. Detection of threee distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients
16. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
17. Single-cell analysis of IL-4 and IFNγ production by T cells from HIV-infected individuals
18. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
19. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state
20. Decay characteristics of HIV-1-infected compartments during combination therapy
21. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
22. Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced hiv disease
23. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
24. Long-lasting recovery in CD4 T cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
25. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovuline, lamivuline, and ritonavir: Results of AIDS clinical trials group protocol 315
26. Perturbation of CD4 and CD8 T cell repertoires during progression to AIDS and regulation of the CD4 repertoire during antiviral therapy
27. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
28. How immune-based interventions can change HIV therapy
29. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the international AIDS Society - USA Panel
30. Antiretroviral treatment in 1998
31. Highly active antiretroviral therapy during early HIV infection reverses T cell activation and maturation abnormalities
32. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy
33. Caution: Should we be treating HIV infection early?
34. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1 infected patients in very early stages. The Spanish EARTH-1 study
35. CD28 cluster report
36. Determination of antigen-specific memory/effector CD4 T cell frequencies by flow cytometry. Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
37. CD4 T cell memory, CD45R subsets and the persistence of antigen unifying concept
38. - cells with ageing
39. Shortened telomeres in the expanded CD28-CD8 cell subset in HIV disease implicate replicative senescence in HIV pathogenesis
40. - T cell expansion - Anergy or activation?
41. The role of CD28 receptor during T cell responses to antigen
42. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: Correlation with decreased CD28 expression
43. Low T cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS
44. Lack of T cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease
45. Cytokines induce the development of functionally heterogeneous T helper cell subsets
46. Circulating HIV-specific CD8 cytotoxic T cells express CD38 and HLA-DR antigens
47. Rapid effector function in CD8 memory T cells
48. Massive expansion of antigen-specific CD8 T cells during an acute virus infection
49. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infections
50. Identification of RANTES, MIP1-α and MIP1-β as the major HIV-suppressive factors produced by CD8 T cells
51. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
52. Co-receptors for HIV-1 entry
53. Chemokines and T lympbocytes: More than an attraction
54. Change in circulating levels of chemokines macrophage inflammatory proteins 1 alpha and 1 beta, RANTES, monocytic chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir
55. Toward HIV eradication or remission: The tasks ahead
56. HIV infection: How effective is drug combination treatment?